Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Public vaccine manufacturing capacity in the Latin American and Caribbean region: current status and perspectives.

Cortes Mde L, Cardoso D, Fitzgerald J, DiFabio JL.

Biologicals. 2012 Jan;40(1):3-14. doi: 10.1016/j.biologicals.2011.09.013. Epub 2011 Oct 26. Review.

PMID:
22033155
2.
3.

The acute administration of either amiloride or captopril does not prevent endothelial dysfunction induced by ischemia and reperfusion in the human forearm vasculature.

Luca MC, Liuni A, DiFabio J, Gori T, Parker JD.

Can J Physiol Pharmacol. 2010 Oct;88(10):996-1001. doi: 10.1139/y10-081.

PMID:
20962899
4.

Continuous therapy with transdermal nitroglycerin does not affect biomarkers of vascular inflammation and injury in healthy volunteers.

Thomas GR, DiFabio JM, Gori T, Jenkins DJ, Parker JD.

Can J Physiol Pharmacol. 2009 Jun;87(6):455-9. doi: 10.1139/y09-030.

PMID:
19526040
5.

Once daily therapy with isosorbide-5-mononitrate causes endothelial dysfunction in humans: evidence of a free-radical-mediated mechanism.

Thomas GR, DiFabio JM, Gori T, Parker JD.

J Am Coll Cardiol. 2007 Mar 27;49(12):1289-95. Epub 2007 Mar 12.

6.

Nitroglycerin attenuates human endothelial progenitor cell differentiation, function, and survival.

DiFabio JM, Thomas GR, Zucco L, Kuliszewski MA, Bennett BM, Kutryk MJ, Parker JD.

J Pharmacol Exp Ther. 2006 Jul;318(1):117-23. Epub 2006 Apr 18.

PMID:
16622039
7.

Role of mitochondrial aldehyde dehydrogenase in nitrate tolerance.

DiFabio J, Ji Y, Vasiliou V, Thatcher GR, Bennett BM.

Mol Pharmacol. 2003 Nov;64(5):1109-16.

PMID:
14573760
8.

State of immunization in the Americas.

de Quadros CA, Tambini G, DiFabio JL, Brana M, Santos JI.

Infect Dis Clin North Am. 2000 Mar;14(1):241-57, xi. Review.

PMID:
10738681
9.

Introduction of Hib conjugate vaccines in the non-industrialized world: experience in four 'newly adopting' countries.

Wenger JD, DiFabio J, Landaverde JM, Levine OS, Gaafar T.

Vaccine. 1999 Nov 12;18(7-8):736-42.

PMID:
10547434
10.

Surveillance for Streptococcus pneumoniae in Latin American children.

Kertesz DA, Spika JS, Talbot JA, Difabio JL.

Can J Infect Dis. 1996 Jan;7(1):21-3. No abstract available.

11.

Stimulation of protective antibodies against type Ia and Ib group B streptococci by a type Ia polysaccharide-tetanus toxoid conjugate vaccine.

Wessels MR, Paoletti LC, Rodewald AK, Michon F, DiFabio J, Jennings HJ, Kasper DL.

Infect Immun. 1993 Nov;61(11):4760-6.

12.

Group B Streptococcus type II polysaccharide-tetanus toxoid conjugate vaccine.

Paoletti LC, Wessels MR, Michon F, DiFabio J, Jennings HJ, Kasper DL.

Infect Immun. 1992 Oct;60(10):4009-14.

13.

Effects of chain length on the immunogenicity in rabbits of group B Streptococcus type III oligosaccharide-tetanus toxoid conjugates.

Paoletti LC, Kasper DL, Michon F, DiFabio J, Jennings HJ, Tosteson TD, Wessels MR.

J Clin Invest. 1992 Jan;89(1):203-9.

14.

Structural determination and immunochemical characterization of the type V group B Streptococcus capsular polysaccharide.

Wessels MR, DiFabio JL, Benedì VJ, Kasper DL, Michon F, Brisson JR, Jelínková J, Jennings HJ.

J Biol Chem. 1991 Apr 15;266(11):6714-9.

15.

Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus.

Wessels MR, Paoletti LC, Kasper DL, DiFabio JL, Michon F, Holme K, Jennings HJ.

J Clin Invest. 1990 Nov;86(5):1428-33.

16.

An oligosaccharide-tetanus toxoid conjugate vaccine against type III group B Streptococcus.

Paoletti LC, Kasper DL, Michon F, DiFabio J, Holme K, Jennings HJ, Wessels MR.

J Biol Chem. 1990 Oct 25;265(30):18278-83.

17.

Isolation and characterization of type IV group B Streptococcus capsular polysaccharide.

Wessels MR, Benedí WJ, Jennings HJ, Michon F, DiFabio JL, Kasper DL.

Infect Immun. 1989 Apr;57(4):1089-94.

18.

The heterogeneity of the non-aggregating proteoglycans of the human intervertebral disc.

DiFabio JL, Pearce RH, Caterson B, Hughes H.

Biochem J. 1987 May 15;244(1):27-33.

19.

Preparation of oligosaccharides by the action of bacteriophage-borne enzymes on Klebsiella capsular polysaccharides.

Dutton GG, DiFabio JL, Leek DM, Merrifield EH, Nunn JR, Stephen AM.

Carbohydr Res. 1981 Nov 2;97(1):127-38.

PMID:
7307018

Supplemental Content

Loading ...
Support Center